Investor Relations

Progenra Inc. sees significant market opportunities in developing products to treat cancer/immune-oncology, inflammatory diseases, cystic fibrosis, neurodegenerative diseases such as Parkinson's and Alzheimer's, metabolic diseases, and cardiovascular disease. We use an exclusive research platform to identify novel therapeutic medicines based on the ubiquitin and ubiquitin-like pathways. We seek to add value to existing pharmaceutical and biotechnology company ventures and to create new programs with interested parties. Progenra invites partnership, funding and investment opportunities from both small and large institutions.

Please contact Progenra's Business Development office for further discussion.